Epidemiological mapping of drug-susceptible and resistant tuberculosis in 30 WHO high-burden countries: Three decades of GBD 2023 trends, projections to 2043 and concordance with WHO estimates
Saudi Medical Journal · 2026
DOI: 10.15537/1658-3175.1070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Medical Journal, 2026. Verfasst von Azfar A Ishaqui und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Tuberculosis. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
Tuberculosis (TB) continues to drive infectious mortality worldwide. The study characterized the evolution of drug-susceptible TB (DS-TB), multidrug-resistant TB (MDR-TB), and extensively drug-resistant TB (XDR-TB) in 30 WHO high-burden countries, linking current patterns to long-term trends, age structure, and forward-looking scenarios to 2043.
Methods
Using GBD 2023 estimates for 1990–2023, we extracted incidence, mortality, and DALYs as age-standardized rates (ASR) per 100,000 with 95% uncertainty intervals. Temporal dynamics were summarized with Estimated Annual Percent Change (EAPC) and extended linearly to 2043. GBD incidence and mortality were compared against WHO national TB series for 2010–2023.
Results
Overall TB incidence ASR declined in 28/30 countries between 1990 and 2023, ranging from a 79.2% reduction in Bangladesh to a 24.9% increase in the Philippines. Mortality and DALY ASR decreased in 29/30 countries. DS-TB incidence dropped in 28/30 settings, while MDR-TB incidence rose in 28/30, from -62.5% in China to +23,603% in Kyrgyzstan. The MDR/RR-TB burden shifted toward older adults (≥ 55 years) in countries such as China (+22 percentage points), whereas youth contributions remained high in Nigeria (∼40%). Projections assuming constant EAPC suggest continued DS-TB declines but sustained MDR-TB in Eastern Europe and Central Asia.
Conclusion
The MDR-TB remains concentrated and often increasing with limited detectable XDR-TB. Age-tailored interventions, universal drug-susceptibility testing, scale-up of all-oral second-line regimens, and adherence support are critical to reverse resistant-TB trajectories while preserving gains against DS-TB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
- Faculty of Pharmacy, Iqra University, Karachi 75500, Pakistan.
- Department of Pharmacology, Faculty of Pharmacy & Pharmaceutical Sciences, University of Karachi, Karachi 75270, Pakistan.
- Department of Pharmacy Practice, Faculty of Pharmacy, University of Sindh, Jamshoro 76080, Pakistan.
- Department of Pharmacognosy, Faculty of Pharmacy & Pharmaceutical Sciences, University of Karachi, Karachi 75270, Pakistan.
- Department of Pharmacy, University of Lahore, Lahore 54000, Pakistan.
ORCID-Profile: Azfar A Ishaqui, Salman A Ahmad
Zitieren
APA
Ishaqui, A. A., Ahmad, S. A., Alam, S., Kumar, N., Farooq, J., Orayj, K., Ahmad, R., Zawiah, M., Mohammed, M., Imran, M., Khalil, A. A. A., Kaddoura, M. A., Alshahrani, S. M., Iqbal, A., & Maqsood, M. B. (2026). Epidemiological mapping of drug-susceptible and resistant tuberculosis in 30 WHO high-burden countries: Three decades of GBD 2023 trends, projections to 2043 and concordance with WHO estimates. Saudi Medical Journal. https://doi.org/10.15537/1658-3175.1070
Vancouver
Ishaqui AA, Ahmad SA, Alam S, Kumar N, Farooq J, Orayj K, et al. Epidemiological mapping of drug-susceptible and resistant tuberculosis in 30 WHO high-burden countries: Three decades of GBD 2023 trends, projections to 2043 and concordance with WHO estimates. Saudi Medical Journal. 2026. doi:10.15537/1658-3175.1070
BibTeX
@article{Ishaqui2026,
author = {Ishaqui, Azfar A and Ahmad, Salman A and Alam, Shoaib and Kumar, Narendar and Farooq, Javeria and Orayj, Khalid and Ahmad, Rabbiya and Zawiah, Mohammed and Mohammed, Mustapha and Imran, Muhammad and Khalil, Asaad A Asaad and Kaddoura, Mohammed A and Alshahrani, Sultan M and Iqbal, Adnan and Maqsood, Muhammad B},
title = {Epidemiological mapping of drug-susceptible and resistant tuberculosis in 30 WHO high-burden countries: Three decades of GBD 2023 trends, projections to 2043 and concordance with WHO estimates},
journal = {Saudi Medical Journal},
year = {2026},
doi = {10.15537/1658-3175.1070}
}
EUVIMED